Company intelligence
Celerion
Celerion Can Take You from First-In-Human through Proof-of-Concept.
About Celerion
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings. Our operations are strategically located in: Lincoln, Nebraska (Corporate Headquarters) Philadelphia, Pennsylvania Phoenix, Arizona Belfast, Northern Ireland,UK Zurich, Switzerland Vienna, Austria Richmond, Virginia Montreal, Quebec, Canada For more information, visit: www.celerion.com
Verified activity
Signals from Celerion
3 published signals
Research & Knowledge
Celerion published a recorded webinar titled Best Practices in Clinical Gene Therapy Method Development featuring an AAV Vector Shedding Assay.
Reported by Celerion
Research & Knowledge
Celerion learned that the FDA has officially arrived with a new draft guidance on Hepatic Impairment PK studies.
Reported by Celerion
People
Celerion is hiring full-time and part-time opportunities in Lincoln, NE, Tempe, AZ, and Richmond, VA.
Reported by Celerion